Advertisement

Extrapleural Pneumonectomy

  • Ju-Mei Ng
Chapter

Abstract

Extrapleural pneumonectomy (EPP) is a formidable surgical procedure performed on patients with limited life expectancy. Anesthetic management may contribute to containment of perioperative morbidity and mortality through the control of intraoperative physiologic disruptions and postoperative pain, and an appreciation of the associated postoperative complications to effect early intervention. Beyond standard anesthetic management issues for pneumonectomy, there exist a number of important “EPP-specific” anesthetic concerns. These include significantly greater blood loss, more delicate management of intravascular fluid and blood components, greater operative impairment of venous return, high probability of arrhythmias and greater potential for hemodynamic instability related to pericardial window and its patch. Common causes of hypotension during EPP include compression of the heart or great vessels by tumor or surgical pressure/retraction, blood loss and/or inadequate fluid resuscitation and thoracic epidural sympathetic blockade. No single anesthetic recipe is of proven superiority for either EPP or lung resection surgery in general. The priority for early extubation favors the use of short-acting modern inhalational and intravenous agents, with limited use of ­traditional parenteral narcotics. Thoracic epidural analgesia is widely employed intraoperatively to facilitate extubation at the conclusion of surgery by providing dense analgesia without depression of sensorium or respiratory drive. Fluid management remains a challenge due to the increased blood loss in EPP, hemodynamic instability, renal toxicity of chemotherapy agents, and the potential for exacerbation of acute lung injury.

Keywords

Acute Lung Injury Venous Return Malignant Pleural Mesothelioma Thoracic Epidural Analgesia Dependent Lung 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1.  1.
    Butchart EG, Ashcroft T, Barnsley WC, Holden MP. Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura. Experience with 29 patients. Thorax. 1976;31:15–24.PubMedCrossRefGoogle Scholar
  2.  2.
    Sugarbaker DJ, Jaklitsch MT, Bueno R, et al. Prevention, early detection, and management of complications after 328 consecutive extrapleural pneumonectomies. J Thorac Cardiovasc Surg. 2004;128:138–46.PubMedCrossRefGoogle Scholar
  3.  3.
    Tilleman TR, Richards WG, Zellos L, et al. Extrapleural pneumonectomy followed by intracavitary intraoperative hyperthermic cisplatin with pharmacologic cytoprotection for treatment of malignant pleural mesothelioma: a phase II prospective study. J Thorac Cardiovasc Surg. 2009;138:405–11.PubMedCrossRefGoogle Scholar
  4.  4.
    de Perrot M, McRae K, Anraku M, et al. Risk factors for major complications after extrapleural pneumonectomy for malignant pleural mesothelioma. Ann Thorac Surg. 2008;85:1206–10.PubMedCrossRefGoogle Scholar
  5.  5.
    Harpole DH, Liptay MJ, DeCamp Jr MM, et al. Prospective analysis of pneumonectomy: risk factors for major morbidity and cardiac dysrhythmias. Ann Thorac Surg. 1996;61:977–82.PubMedCrossRefGoogle Scholar
  6.  6.
    Opitz I, Kestenholz P, Lardinois D, et al. Incidence and management of complications after neoadjuvant chemotherapy followed by extrapleural pneumonectomy for malignant pleural mesothelioma. Eur J Cardiothorac Surg. 2006;29:579–84.PubMedCrossRefGoogle Scholar
  7.  7.
    Sugarbaker DJ, Flores RM, Jaklitsch MT, et al. Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients. J Thorac Cardiovasc Surg. 1999;117:54–63. discussion 63–55.PubMedCrossRefGoogle Scholar
  8.  8.
    Krug LM, Pass HI, Rusch VW, et al. Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma. J Clin Oncol. 2009;27:3007–13.PubMedCrossRefGoogle Scholar
  9.  9.
    de Perrot M, Feld R, Cho BC, et al. Trimodality therapy with induction chemotherapy followed by extrapleural pneumonectomy and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma. J Clin Oncol. 2009;27:1413–8.PubMedCrossRefGoogle Scholar
  10. 10.
    Hartigan PM, Ng JM. Anesthetic strategies for patients undergoing extrapleural pneumonectomy. Thorac Surg Clin. 2004;14:575–83, xi.Google Scholar
  11. 11.
    Ng JM, Hartigan PM. Anesthetic management of patients undergoing extrapleural pneumonectomy for mesothelioma. Curr Opin Anaesthesiol. 2008;21:21–7.PubMedCrossRefGoogle Scholar
  12. 12.
    Zellos L, Christiani DC. Epidemiology, biologic behavior, and natural history of mesothelioma. Thorac Surg Clin. 2004;14:469–77, viii.Google Scholar
  13. 13.
    Wagner JC, Sleggs CA, Marchand P. Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province. Br J Ind Med. 1960;17:260–71.PubMedGoogle Scholar
  14. 14.
    Carbone M, Kratzke RA, Testa JR. The pathogenesis of mesothelioma. Semin Oncol. 2002;29:2–17.PubMedCrossRefGoogle Scholar
  15. 15.
    Weder W, Opitz I, Stahel R. Multimodality strategies in malignant pleural mesothelioma. Semin Thorac Cardiovasc Surg. 2009;21:172–6.PubMedCrossRefGoogle Scholar
  16. 16.
    Carroll N, Mohamed F, Sugarbaker P. Hyperthermic chemoperfusion, and postoperative chemotherapy: The National Cancer Institute and Washington Hospital Center experience. In: Pass H, Vogelzang N, Carbone M, editors. Malignant mesothelioma: advances in pathogenesis, diagnosis and translational therapies. New York: Springer; 2005. p. 732–54.Google Scholar
  17. 17.
    Lee JM, Sugarbaker DJ. Extrapleural pneumonectomy for diffuse malignant pleural mesothelioma and other diffuse pleural malignancies. In: Sugarbaker DJ, Bueno R, Krasna MJ, Mentzer SJ, Zellos L, editors. Adult chest surgery. New York: McGraw-Hill; 2009. p. 868–84.Google Scholar
  18. 18.
    Reilly Jr JJ. Evidence-based preoperative evaluation of candidates for thoracotomy. Chest. 1999;116:474S–6.PubMedCrossRefGoogle Scholar
  19. 19.
    Amar D, Burt ME, Roistacher N, et al. Value of perioperative Doppler echocardiography in patients undergoing major lung resection. Ann Thorac Surg. 1996;61:516–20.PubMedCrossRefGoogle Scholar
  20. 20.
    Gill RR, Gerbaudo VH, Sugarbaker DJ, Hatabu H. Current trends in radiologic management of malignant pleural mesothelioma. Semin Thorac Cardiovasc Surg. 2009;21:111–20.PubMedCrossRefGoogle Scholar
  21. 21.
    Slinger P. Update on anesthetic management for pneumonectomy. Curr Opin Anaesthesiol. 2009;22:31–7.PubMedCrossRefGoogle Scholar
  22. 22.
    Wittnich C, Trudel J, Zidulka A, Chiu RC. Misleading “pulmonary wedge pressure” after pneumonectomy: its importance in postoperative fluid therapy. Ann Thorac Surg. 1986;42:192–6.PubMedCrossRefGoogle Scholar
  23. 23.
    Brister NW, Barnette RE, Kim V, Keresztury M. Anesthetic considerations in candidates for lung volume reduction surgery. Proc Am Thorac Soc. 2008;5:432–7.PubMedCrossRefGoogle Scholar
  24. 24.
    Ballantyne JC, Carr DB, deFerranti S, et al. The comparative effects of postoperative analgesic therapies on pulmonary outcome: cumulative meta-analyses of randomized, controlled trials. Anesth Analg. 1998;86:598–612.PubMedGoogle Scholar
  25. 25.
    Beattie WS, Badner NH, Choi P. Epidural analgesia reduces postoperative myocardial infarction: a meta-analysis. Anesth Analg. 2001;93:853–8.PubMedCrossRefGoogle Scholar
  26. 26.
    Oka T, Ozawa Y, Ohkubo Y. Thoracic epidural bupivacaine attenuates supraventricular tachyarrhythmias after pulmonary resection. Anesth Analg. 2001;93:253–9.PubMedGoogle Scholar
  27. 27.
    Nino M, Body SC, Hartigan PM. The use of a bronchial blocker to rescue an ill-fitting double-lumen endotracheal tube. Anesth Analg. 2000;91:1370–1.PubMedCrossRefGoogle Scholar
  28. 28.
    Slinger P. Pro: low tidal volume is indicated during one-lung ventilation. Anesth Analg. 2006;103:268–70.PubMedCrossRefGoogle Scholar
  29. 29.
    Hurford WE, Kolker AC, Strauss HW. The use of ventilation/perfusion lung scans to predict oxygenation during one-lung anesthesia. Anesthesiology. 1987;67:841–4.PubMedCrossRefGoogle Scholar
  30. 30.
    Bakaeen F, Rice D, Correa AM, et al. Use of aprotinin in extrapleural pneumonectomy: effect on hemostasis and incidence of complications. Ann Thorac Surg. 2007;84:982–6.PubMedCrossRefGoogle Scholar
  31. 31.
    Slinger PD. Perioperative fluid management for thoracic surgery: the puzzle of postpneumonectomy pulmonary edema. J Cardiothorac Vasc Anesth. 1995;9:442–51.PubMedCrossRefGoogle Scholar
  32. 32.
    Passman RS, Gingold DS, Amar D, et al. Prediction rule for atrial fibrillation after major noncardiac thoracic surgery. Ann Thorac Surg. 2005;79:1698–703.PubMedCrossRefGoogle Scholar
  33. 33.
    Roselli EE, Murthy SC, Rice TW, et al. Atrial fibrillation complicating lung cancer resection. J Thorac Cardiovasc Surg. 2005;130:438–44.PubMedCrossRefGoogle Scholar
  34. 34.
    Amar D, Roistacher N, Burt ME, et al. Effects of diltiazem versus digoxin on dysrhythmias and cardiac function after pneumonectomy. Ann Thorac Surg. 1997;63:1374–81. discussion 1372–81.PubMedGoogle Scholar
  35. 35.
    Amar D, Roistacher N, Rusch VW, et al. Effects of diltiazem prophylaxis on the incidence and clinical outcome of atrial arrhythmias after thoracic surgery. J Thorac Cardiovasc Surg. 2000;120:790–8.PubMedCrossRefGoogle Scholar
  36. 36.
    Dunning J, Treasure T, Versteegh M, Nashef SA. Guidelines on the prevention and management of de novo atrial fibrillation after cardiac and thoracic surgery. Eur J Cardiothorac Surg. 2006;30:852–72.PubMedCrossRefGoogle Scholar
  37. 37.
    Brown MJ, Brown DR. Thoracic cavity irrigation: an unusual cause of acute ST segment increase. Anesth Analg. 2002;95:552–4.PubMedGoogle Scholar
  38. 38.
    Obata H, Saito S, Fujita N, et al. Epidural block with mepivacaine before surgery reduces long-term post-thoracotomy pain. Can J Anaesth. 1999;46:1127–32.PubMedCrossRefGoogle Scholar
  39. 39.
    Senturk M, Ozcan PE, Talu GK, et al. The effects of three different analgesia techniques on long-term postthoracotomy pain. Anesth Analg. 2002;94:11–5.PubMedCrossRefGoogle Scholar
  40. 40.
    Suzuki M, Haraguti S, Sugimoto K, et al. Low-dose intravenous ketamine potentiates epidural analgesia after thoracotomy. Anesthesiology. 2006;105:111–9.PubMedCrossRefGoogle Scholar
  41. 41.
    Wolf AS, Daniel J, Sugarbaker DJ. Surgical techniques for multimodality treatment of malignant pleural mesothelioma: extrapleural pneumonectomy and pleurectomy/decortication. Semin Thorac Cardiovasc Surg. 2009;21:132–48.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  • Ju-Mei Ng
    • 1
  1. 1.Department of Anesthesiology, Perioperative and Pain MedicineBrigham and Women’s HospitalBostonUSA

Personalised recommendations